Trial finds new drug safe, effective to treat deadliest form of epilepsy
October 18, 2024
The University of Cincinnati’s Brandon Foreman, MD, presented Phase 3 clinical trial results at the Neurocritical Care Society’s 22nd Annual Meeting this week in San Diego, California that found ganaxolone is a safe and effective treatment for refractory status epilepticus.